Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis.
Sara CarazoMarie-Noëlle BillardAmélie BoutinGaston De SerresPublished in: BMC infectious diseases (2020)
Earlier age at MCV1 decreases measles protection and immunogenicity after one dose and might still have an impact on vaccine failures after two doses of measles vaccine. While two-dose vaccination coverage is most critical to interrupt measles transmission, older age at first vaccination may be necessary to keep the high level of population immunity needed to maintain it.